Trial Profile
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2020
Price :
$35
*
At a glance
- Drugs GSK 2321138A (Primary) ; Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- 01 Jul 2013 Planned End Date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 20 Feb 2013 Planned End Date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 27 Apr 2012 Planned end date changed from 1 Oct 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.